🔴 Neurosense Therapeutics is trading 10.2% down in after-hours trading after announcing 1-for-20 reverse share split

Neurosense Therapeutics is trading 10.2% down now at $0.36 after announcing a 1-for-20 reverse share split.

• It closed at $0.40 on September 9, 2026.
• The split will reduce outstanding shares from 37,938,036 to approximately 1,896,902.
• Post-split trading is scheduled to begin September 14, 2026; warrants and options will be adjusted proportionately.